Latest filings (excl ownership)
10-Q
2024 Q2
Quarterly report
6 Aug 24
8-K
Certara Reports Second Quarter 2024 Financial Results
6 Aug 24
8-K
Amendments to Articles of Incorporation or Bylaws
19 Jul 24
8-K
Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio
9 Jul 24
8-K
Entry into a Material Definitive Agreement
26 Jun 24
8-K
Submission of Matters to a Vote of Security Holders
23 May 24
10-Q
2024 Q1
Quarterly report
7 May 24
8-K
Certara Reports First Quarter 2024 Financial Results
7 May 24
DEFA14A
Additional proxy soliciting materials
12 Apr 24
ARS
2023 FY
Annual report to shareholders
10 Apr 24
DEFA14A
Additional proxy soliciting materials
10 Apr 24
DEF 14A
Definitive proxy
10 Apr 24
PRE 14A
Preliminary proxy
29 Mar 24
D
Indefinite amount in equity
27 Mar 24
10-K
2023 FY
Annual report
29 Feb 24
8-K
Certara Reports Fourth Quarter 2023 Financial Results
29 Feb 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
8-K
Certara Reports Third Quarter 2023 Financial Results
8 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
8-K
Certara Reports Second Quarter 2023 Financial Results
9 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
25 May 23
10-Q
2023 Q1
Quarterly report
8 May 23
8-K
Certara Reports First Quarter 2023 Financial Results
8 May 23
ARS
2022 FY
Annual report to shareholders
10 Apr 23
DEFA14A
Additional proxy soliciting materials
10 Apr 23
DEF 14A
Definitive proxy
10 Apr 23
8-K
Departure of Directors or Certain Officers
31 Mar 23
10-K
2022 FY
Annual report
1 Mar 23
8-K
Certara Reports Fourth Quarter and Full Year 2022 Financial Results
1 Mar 23
8-K
Certara Announces Transition Plan for Chief Financial Officer
1 Mar 23
8-K
Departure of Directors or Certain Officers
23 Dec 22
8-K
Certara Announces the Completion of Arsenal Capital Partners’ Investment and the Appointment of David Spaight to the Board of Directors
8 Dec 22
10-Q
2022 Q3
Quarterly report
7 Nov 22
8-K
Certara Reports Third Quarter 2022 Financial Results
7 Nov 22
8-K
Arsenal Capital Partners Increases Investment in Global Biosimulation Leader Certara with $449M Stock Purchase
7 Nov 22
8-K
Other Events
15 Aug 22
8-K
Departure of Directors or Certain Officers
12 Aug 22
424B7
Prospectus with selling stockholder info
12 Aug 22
FWP
Free writing prospectus
11 Aug 22
10-Q
2022 Q2
Quarterly report
9 Aug 22
Latest ownership filings
4
Leif E Pedersen
10 Sep 24
144
Notice of proposed sale of securities
9 Sep 24
4
Robert Aspbury
2 Jul 24
4
Daniel Corcoran
3 Jun 24
4
Rona Anhalt
3 Jun 24
3
Rona Anhalt
30 May 24
3
Daniel Corcoran
30 May 24
4
MATTHEW M WALSH
23 May 24
4
Nancy Killefer
23 May 24
4
Rosemary A Crane
23 May 24
4
Cynthia Collins
23 May 24
4
JAMES E CASHMAN III
23 May 24
4
ERAN BROSHY
23 May 24
4/A
William F Feehery
5 Apr 24
4
PATRICK F SMITH
4 Apr 24
4
Richard M. Traynor
3 Apr 24
4
PATRICK F SMITH
3 Apr 24
4
NICOLETTE D SHERMAN
3 Apr 24
4
Leif E Pedersen
3 Apr 24
4
John E Gallagher
3 Apr 24
4
Robert Aspbury
3 Apr 24
4
William F Feehery
3 Apr 24
144
Notice of proposed sale of securities
2 Apr 24
144
Notice of proposed sale of securities
1 Apr 24
4
Richard M. Traynor
6 Mar 24
4
NICOLETTE D SHERMAN
6 Mar 24
4
Leif E Pedersen
6 Mar 24
4
William F Feehery
6 Mar 24
4
Robert Aspbury
6 Mar 24
4
Richard M. Traynor
5 Mar 24
144
Notice of proposed sale of securities
4 Mar 24
4
PATRICK F SMITH
21 Feb 24
144
Notice of proposed sale of securities
20 Feb 24
4
Richard M. Traynor
14 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
144
Notice of proposed sale of securities
12 Feb 24
SC 13G/A
BAILLIE GIFFORD & CO
30 Jan 24
SC 13G
BlackRock Inc.
25 Jan 24
4
Richard M. Traynor
27 Dec 23
144
Notice of proposed sale of securities
26 Dec 23